Adaptive Biotechnologies Enters Partnership for Use Of clonoSEQ® as Preferred MRD Test for Drug Development Across Amgen’s Hematology Franchise

Ads

You May Also Like

STAT-Dx Unveils New In-Vitro Diagnostic System DiagCORE®

STAT-Dx Unveils New In-Vitro Diagnostic System DiagCORE® Fully-Integrated, Molecular Diagnostics System Unveiled at ECCMID ...

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2016 Financial Results

BERKELEY HEIGHTS, N.J., March 21, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ...

Santhera Reports Preliminary Key Financial Figures for 2016 and Provides Corporate Update

Liestal, Switzerland, January 26, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces preliminary, unaudited key financial figures ...